Profile cover photo
Profile photo
Smart Consulting Group
10 followers -
Smart Pharmaceutical Consultants boosting Pharma Profits with Lean Pharma principles
Smart Pharmaceutical Consultants boosting Pharma Profits with Lean Pharma principles

10 followers
About
Posts

Post has attachment

Post has attachment

Post has attachment

Post has attachment

Post has attachment

FDA REGULATORY AND COMPLIANCE NEWS
• Last week, FDA announced the availability of a draft guidance for industry entitled, “Deviation Reporting for Human Cells, Tissues, and Cellular and Tissue-Based Products Regulated Solely Under Section 361 of the Public Health Service Act and 21 CFR Part 1271.” The draft guidance document provides certain establishments that manufacture non-reproductive human cells, tissues, and cellular and tissue-based products (HCT/Ps), regulated solely under the Public Health Service Act and under FDA regulations, with recommendations and relevant examples for complying with the requirements to report HCT/P deviations.

Post has attachment

Post has attachment

Post has attachment

Post has attachment
Wait while more posts are being loaded